AZN

AstraZeneca PLC

D
AZN
USD
-0.12
(-0.1558%)
Market Closed
217,542.00
Volume
4.23286
EPS
1.89
Div Yield
37.748
P/E
238,488,156,246.00
Market Cap
Today
-0.1558%
1 Week
-0.350%
1 Month
12.243%
6 Months
19.963%
12 Months
2.958%
Year To Date
14.209%
All Time
134.048%
News

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
MRK
MRK
0.3
(0.2292%)
USD
PFE
PFE
-0.28
(-0.9679%)
USD
GSK
GSK
0.1
(0.2228%)
USD
NVS
NVS
-0.15
(-0.146%)
USD
JNJ
JNJ
0.35
(0.2268%)
USD
SNY
SNY
-0.2
(-0.4094%)
USD
ABBV
ABBV
2.1
(1.2775%)
USD
M
MRNA
0.2
(0.1507%)
USD

Title:
AstraZeneca PLC

Sector:
Healthcare
Industry:
Drug Manufacturers - General
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.
Do you need help or have a question?
Contact Us